Since phytochemicals remain a partially explored pool of therapeutic strategies, the present study was intended to virtually screen the 44 natural BDNF inducers against the AChE, BuChE, GSK3β, MOAA, MOAB, NDMA proteins to identify potential therapeutic candidates for AD treatment. Here, GSK3B is linked to Alzheimer disease.